QRG Capital Management Inc. Has $537,000 Holdings in Mettler-Toledo International, Inc. $MTD

QRG Capital Management Inc. decreased its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 6.5% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 457 shares of the medical instruments supplier’s stock after selling 32 shares during the quarter. QRG Capital Management Inc.’s holdings in Mettler-Toledo International were worth $537,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of MTD. Alliancebernstein L.P. lifted its holdings in Mettler-Toledo International by 21.6% during the 1st quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock worth $837,653,000 after buying an additional 126,147 shares in the last quarter. PineStone Asset Management Inc. lifted its holdings in Mettler-Toledo International by 41.9% during the 2nd quarter. PineStone Asset Management Inc. now owns 334,349 shares of the medical instruments supplier’s stock worth $392,766,000 after buying an additional 98,737 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Mettler-Toledo International by 42.0% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 305,722 shares of the medical instruments supplier’s stock worth $361,030,000 after buying an additional 90,395 shares in the last quarter. Nuveen LLC acquired a new position in Mettler-Toledo International during the 1st quarter worth $71,897,000. Finally, Jones Financial Companies Lllp lifted its holdings in Mettler-Toledo International by 27,938.9% during the 1st quarter. Jones Financial Companies Lllp now owns 49,068 shares of the medical instruments supplier’s stock worth $57,945,000 after buying an additional 48,893 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on MTD shares. Evercore ISI increased their price target on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a research note on Tuesday. Weiss Ratings reissued a “hold (c)” rating on shares of Mettler-Toledo International in a research note on Wednesday. JPMorgan Chase & Co. increased their price target on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a research note on Thursday. Robert W. Baird increased their price target on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a “neutral” rating in a research note on Monday, August 4th. Finally, Citigroup increased their price target on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a research note on Thursday, August 21st. Five analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat.com, Mettler-Toledo International has a consensus rating of “Hold” and an average target price of $1,336.50.

Mettler-Toledo International Stock Down 2.5%

MTD opened at $1,274.39 on Friday. Mettler-Toledo International, Inc. has a 12 month low of $946.69 and a 12 month high of $1,486.76. The company has a fifty day simple moving average of $1,278.97 and a 200 day simple moving average of $1,190.04. The stock has a market cap of $26.25 billion, a P/E ratio of 32.27, a P/E/G ratio of 3.92 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.58 by $0.51. The firm had revenue of $983.22 million during the quarter, compared to analysts’ expectations of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The company’s revenue was up 3.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $9.65 EPS. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, equities research analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Mettler-Toledo International news, insider Gerry Keller sold 165 shares of the stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the completion of the transaction, the insider owned 94 shares in the company, valued at approximately $123,012.16. This represents a 63.71% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Shawn Vadala sold 300 shares of the stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $1,254.09, for a total value of $376,227.00. Following the transaction, the chief financial officer owned 5,095 shares of the company’s stock, valued at approximately $6,389,588.55. This trade represents a 5.56% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 1,827 shares of company stock worth $2,371,208. Corporate insiders own 1.94% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.